The findings of the study indicated that the TIDE score of the group with high expression of THSD7A was notably greater than that of the group with low expression, which indicated that immunotherapy may be less successful in gastric cancer patients with elevated THSD7A expression (Supplementary Figure 1A). Here, THSD7A is linked to gastric cancer.